Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- EpiPen Is Milestone for the Future: Mr Diehl of Merck Ltd.
September 8, 2003
- NEW PRODUCTS
September 1, 2003
- 4 New Drugs, Including Pegasys, Visudyne Recommended for Approval
September 1, 2003
- Insurance Medical Costs Fell 0.7% in FY2002: Korosho
September 1, 2003
- 1 in 5 Japanese May Suffer from Diabetes: Korosho Survey
September 1, 2003
- BI to Further Collaborate with Japanese Firms: Prof. Krebs
September 1, 2003
- REGULATORY NEWS IN BRIEF
September 1, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 1, 2003
- ON THE MOVE
September 1, 2003
- Dainippon to Promote Better Cancer Pain Management
September 1, 2003
- Don Quijote to Provide Free OTC Drugs in Late Night Emergencies
September 1, 2003
- Merck & Co. Determined to Acquire All Shares of Banyu
September 1, 2003
- Anti-fatigue Food, Drug Development Project to Start from October: Soiken
September 1, 2003
- Antitumor Drug TZT-1027 Could Be Major Global Product: Teikoku Hormone
September 1, 2003
- G&G Enters Capital, Business Tie-up with Toyo Pharmar
September 1, 2003
- Kaken Considers Global Development with Fiblast
September 1, 2003
- Shipment of PPA-containing OTC Drugs Stopped
September 1, 2003
- Neoral Patent Litigation Between Novartis and Merck Hoei Continues
September 1, 2003
- BULLETIN
September 1, 2003
- Kyowa, Kyorin to Copromote Allelock to Facilities with Less than 100 Beds
September 1, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…